DaVita (MIL:1DVA) Total Operating Expense: €2,095 Mil (TTM As of Mar. 2026)


MIL:1DVA DaVita Inc MIL:1DVA
61 GF Score
Price €207.10
GF Value €148.57
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is DaVita Total Operating Expense?

DaVita MIL:1DVA 61 Total Operating Expense is €2,095 Mil as of Mar. 2026. GuruFocus rates MIL:1DVA with a GF Score™ of 61/100 and a GF Value™ of €148.57 (Significantly Overvalued). The stock has 6 warning signs investors should review.

DaVita's Total Operating Expense for the three months ended in Mar. 2026 was €519 Mil. DaVita's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was €2,095 Mil.

DaVita Total Operating Expense Related Terms

DaVita Total Operating Expense Historical Data

* Premium members only.

The historical data trend for DaVita's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DaVita Total Operating Expense Chart

DaVita Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,660.22 1,970.88 2,035.21 2,160.40 2,040.19

DaVita Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 509.25 509.37 504.27 562.84 518.78
MIL:1DVA
61GF Score
DaVita Inc MIL:1DVA
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DaVita Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €2,095 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of €2,095 Mil mean?
DaVita (MIL:1DVA) has a Total Operating Expense of €2,095 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on DaVita and its competitors.
Is DaVita's Total Operating Expense too high?
DaVita's current Total Operating Expense is €2,095 Mil. Overall, DaVita has a GF Score™ of 61/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does DaVita's Total Operating Expense compare to THC and EHC?
DaVita's Total Operating Expense of €2,095 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Healthcare Providers & Services company?
A good Total Operating Expense depends on the Healthcare Providers & Services industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on DaVita and its competitors. DaVita's current Total Operating Expense is €2,095 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DaVita stock overvalued right now?
Based on GuruFocus' analysis, DaVita (MIL:1DVA) is currently considered Significantly Overvalued. The stock's GF Value™ is €148.57, compared to a current price of €207.10 — trading 39.4% above its estimated fair value. The current Total Operating Expense is €2,095 Mil. DaVita's overall GF Score™ is 61/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For DaVita (MIL:1DVA), the current Total Operating Expense is €2,095 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DaVita (MIL:1DVA) Overvalued in 2026?

Based on GuruFocus' analysis, DaVita stock appears to be overvalued. The current stock price of €207.10 is trading 39.4% above its estimated GF Value™ of €148.57. GuruFocus considers DaVita to be Significantly Overvalued.

Key valuation signals for MIL:1DVA:

  • Total Operating Expense: €2,095 Mil
  • GF Value™: €148.57 vs. price of €207.10 (39.4% above fair value)
  • GF Score™: 61/100 with 6 warning signs

No single metric tells the full story. See the MIL:1DVA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

DaVita Business Description

Address 2000 16th Street, Denver, CO, USA, 80202
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
61GF Score

Get the complete analysis for MIL:1DVA

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€207.10
Price
€148.57
GF Value